Goodwin Procter advised Ampersand Capital Partners on the deal. Ampersand Capital Partners announced its first and only closing of Ampersand 2022 Limited Partnership with $1.2 billion in...
Ampersand Capital Partners’ $1.2 Billion Closing of Latest Fund
Advent International’s Fundraising
Goodwin advised Advent International on the deal. Advent International announced its fundraising for its flagship fund, Advent International GPE X. The fund reached its hard cap of...
GeneWerk’s Merger with Protagen Protein Services
Goodwin Procter advised GeneWerk on the deal. GeneWerk announced its merger with Protagen Protein Services. GeneWerk, an Ampersand portfolio company, is a cell and gene therapy testing...